🔎 Trials Near Me

Utama › Keadaan Kulit › Illinois

Kajian klinikal Keadaan Kulit di Illinois

7 kajian untuk Keadaan Kulit sedang mencari peserta di lokasi di Illinois.

Bandar di Illinois

Teks kajian rasmi (Bahasa Inggeris)

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

  • Northwestern University, Chicago
  • Northshore University Healthsystem, Skokie
Mengambil pesertaFasa 3
Umur 6 hingga 17 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05723198

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • Endeavor Health, Skokie
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07599813

A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex

  • NU Dermatolgy CTU, Chicago
Mengambil pesertaFasa 2
Umur 2 ke atas · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT07027345

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 2, Rolling Meadows
Mengambil pesertaFasa 2
Umur 18 hingga 74 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT07037901

Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Mengambil pesertaFasa awal 1
6 Months · Semua jantina · Dikemas kini 1 Mei 2026 · NCT05649098

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

  • Arlington Dermatology, Rolling Meadows
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 22 Apr 2026 · NCT07144852

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

  • Arlington Dermatology, Rolling Meadows
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 22 Apr 2026 · NCT07144345

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.